What's New in Active Surveillance for Prostate Cancer

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.
Screenshot (29400).png


In this video, Dr. Aday discusses the latest advancements in active surveillance for prostate cancer. He explains the history of prostate cancer diagnosis and the limitations of the PSA test. He outlines the criteria for eligibility for active surveillance and the protocol for monitoring patients. Dr. Aday also introduces the concept of focal therapy as a potential treatment option for some patients. He emphasizes the importance of regular follow-ups and discusses the future of prostate cancer treatment.


Summary:

  • Dr. Aday is a physician at Sloan Kettering and an active surveillance specialist.
  • The PSA test was introduced in the 1980s and led to an increase in prostate cancer diagnoses.
  • PSA levels alone do not determine the need for immediate treatment.
  • Active surveillance involves regular monitoring to detect changes in Gleason grade and other markers.
  • MRI has revolutionized the detection and monitoring of prostate cancer.
  • Active surveillance is a safe and effective option for low-risk patients.
  • Focal therapy is a potential treatment option that targets specific areas of cancer within the prostate.
  • Personalized treatment decisions are made based on the patient’s age, comorbidities, and preferences.
  • Treatment options include surgery (prostatectomy) and radiation therapy (photon or proton).
  • Advances in technology and research continue to improve prostate cancer treatment.


Key Takeaways:

  • Dr. Aday is an active surveillance specialist at Sloan Kettering.
  • The PSA test led to an increase in prostate cancer diagnoses.
  • Active surveillance involves monitoring Gleason grade and other markers.
  • MRI has revolutionized the detection and monitoring of prostate cancer.
  • Active surveillance is a safe option for low-risk patients.
  • Focal therapy targets specific areas of cancer within the prostate.
  • Treatment decisions are personalized based on age, comorbidities, and preferences.
  • Treatment options include surgery (prostatectomy) and radiation therapy (photon or proton).
  • Advances in technology and research continue to improve prostate cancer treatment.
  • Regular follow-ups are crucial for active surveillance and treatment monitoring.
 
  1. New Treatments and Approaches in Prostate Cancer

    ...Talzenna and Akegga? 2:18 How effective has PSMA been at helping patients delay chemotherapy? 5:08 What was the state of active surveillance in 2023? 5:56 What is Prostox and can it apply to spot radiation? 7:49 What was the state of Pluvicto as a treatment in 2023? 10:02 How have...

    TRT in Patients With Prostate Cancer on Active Surveillance

    ...of treatment-naive patients with prostate cancer on surveillance and they performed a retrospective review of an institutional active surveillance prostate cancer database. Exogenous testosterone has long been attributed to the development and progression of prostate cancer. In fact...

    What's New in Active Surveillance for Prostate Cancer

    In this video, Dr. Aday discusses the latest advancements in active surveillance for prostate cancer. He explains the history of prostate cancer diagnosis and the limitations of the PSA test. He outlines the criteria for eligibility for active surveillanceand the protocol for monitoring...

    Prostate Cancer: Active Surveillance, Advanced Treatments (Live)

    ...the US and internationally. Renowned physicians from different specialties will be covering topics including advanced cancer, active surveillance, radiation treatment, imaging, erectile dysfunction, and incontinence. The conference is led by Mark Moyad, MD, who moderates the Q+A sessions...

    Testosterone Therapy in Men on Active Surveillance

    Testosterone Therapy in Men on Active Surveillance(2022) Tristan Chun, Jacob Tannenbaum, Haley Watts, Igor Voznesensky, Wael Almajed, and Wayne J.G. Hellstrom* Abstract In recent decades, although prostate cancer (PCa) mortality has dramatically decreased, addressing the quality of life for...

    Use of Exogenous T in The Setting Of Screening, Active Surveillance, and After Treatment of Localized Disease

    ...on the use of testosterone replacement therapy among patients with prostate cancer, including in the setting of screening, active surveillance, and after treatment for localized prostate cancer. Beginning, Dr. Khera noted that there has been a paradigm shift with respect to the association...

    PSMA PET, Active Surveillance, ED & Incontinence

    ...the US and internationally. Renowned physicians from different specialties will be covering topics including advanced cancer, active surveillance, radiation treatment, imaging, erectile dysfunction, and incontinence. The conference is led by Mark Moyad, MD, who moderates the Q+A sessions...

  2. How Proscar & Avodart Can Complicate Active Surveillance & Screening

    ...Mark Moyad, MD, MPH asks Matthew Cooperberg, MD, MPH, about the use of Avodart (dutasteride) and Proscar (finasteride) in men on active surveillance. Dr. Cooperberg explains that the early belief that these medications increased the incidence of more aggressive prostate cancers was mistaken...

    High Anxiety with Active Surveillance in Prostate Cancer?

    "I'll never forget that phone call in December 2010. The doctor's name flashed on caller ID. I knew the verdict was in on my prostate biopsy. I held my breath as the urologist told me I had cancer. I had done some homework but nothing prepared me for that call on a Friday evening. There's no way...
 

Online statistics

Members online
8
Guests online
416
Total visitors
424

Latest posts

Back
Top